Skip to main content
Clinical Trials/NL-OMON40597
NL-OMON40597
Withdrawn
Phase 4

Intraarticular treatment of osteoarthrits of the hip: A randomized trial of hyaluronic acid (Fermathron S) vs corticosteroids (Depomedrol). - FermaTrial: hyaluronic acid vs corticosteroid injections in coxarthrosis

Medisch Centrum Leeuwarden0 sites188 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
arthritis of the hip
Sponsor
Medisch Centrum Leeuwarden
Enrollment
188
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Medisch Centrum Leeuwarden

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18 years or older
  • 2\. Symptomatic coxarthritis
  • 3\. Baseline hip pain VAS score of 15 mm or more
  • 4\. Signed informed consent

Exclusion Criteria

  • 1\. Ipsilateral gonarthritis
  • 2\. Clinical significant neurologic or vascular disease
  • 3\. Previous intra\-articular injections in the affected hip
  • 4\. Osteonecrosis or osteomyelitis of the affected hip
  • 5\. Rheumatoid arthritis or other inflammatory arthrides
  • 6\. Previous surgical procedures of the hip
  • 7\. Active or suspected infection in or around the hip
  • 8\. Limitation to give an intra\-articular injection in the affected hip
  • 9\. Current treatement with corticisteroids for another disease
  • 10\. Serious liver or kidney failure

Outcomes

Primary Outcomes

Not specified

Similar Trials